TY - JOUR AU - Trotti, A. AU - Colevas, A. D. AU - Setser, A. AU - Basch, E. PY - 2007 DA - 2007// TI - Patient-reported outcomes and the evolution of adverse event reporting in oncology JO - Journal of Clinical Oncology VL - 25 UR - https://doi.org/10.1200/JCO.2007.12.4784 DO - 10.1200/JCO.2007.12.4784 ID - Trotti2007 ER - TY - JOUR AU - Di, M. M. AU - Gallo, C. AU - Leighl, N. B. AU - Piccirillo, M. C. AU - Daniele, G. AU - Nuzzo, F. PY - 2015 DA - 2015// TI - Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials JO - Journal of Clinical Oncology VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.9334 DO - 10.1200/JCO.2014.57.9334 ID - Di2015 ER - TY - JOUR AU - Basch, E. AU - Iasonos, A. AU - McDonough, T. AU - Barz, A. AU - Culkin, A. AU - Kris, M. G. PY - 2006 DA - 2006// TI - Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: Results of a questionnaire-based study JO - The Lancet Oncology VL - 7 UR - https://doi.org/10.1016/S1470-2045(06)70910-X DO - 10.1016/S1470-2045(06)70910-X ID - Basch2006 ER - TY - STD TI - Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., et al. (2014). Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106(9). ID - ref4 ER - TY - STD TI - Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. ID - ref5 ER - TY - JOUR AU - Basch, E. AU - Deal, A. M. AU - Kris, M. G. AU - Scher, H. I. AU - Hudis, C. A. AU - Sabbatini, P. PY - 2016 DA - 2016// TI - Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial JO - Journal of Clinical Oncology VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.0830 DO - 10.1200/JCO.2015.63.0830 ID - Basch2016 ER - TY - JOUR AU - Berry, D. L. AU - Hong, F. AU - Halpenny, B. AU - Partridge, A. H. AU - Fann, J. R. AU - Wolpin, S. PY - 2014 DA - 2014// TI - Electronic self-report assessment for cancer and self-care support: Results of a multicenter randomized trial JO - Journal of Clinical Oncology VL - 32 UR - https://doi.org/10.1200/JCO.2013.48.6662 DO - 10.1200/JCO.2013.48.6662 ID - Berry2014 ER - TY - STD TI - Denis, F., Yossi, S., Septans, A. L., Charron, A., Voog, E., Dupuis, O., et al. (2017). Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application. American Journal of Clinical Oncology. ID - ref8 ER - TY - STD TI - Denis, F., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., Domont, J., et al. (2017). Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. Journal of the National Cancer Institute, 109(9). ID - ref9 ER - TY - STD TI - US Food and Drug Administration: Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims; Availability 2009. [Available from: https://www.federalregister.gov/documents/2009/12/09/E9-29273/guidance-for-industry-on-patient-reported-outcome-measures-use-in-medical-product-development-to]. Accessed 1 Feb 2019. UR - https://www.federalregister.gov/documents/2009/12/09/E9-29273/guidance-for-industry-on-patient-reported-outcome-measures-use-in-medical-product-development-to ID - ref10 ER - TY - STD TI - Nissen, A., Bager, L., & Pappot, H. (2019). The use of PRO in adverse event identification during cancer therapy - choosing the right questions to ask. Acta oncologica (Stockholm, Sweden), 1–7. ID - ref11 ER - TY - JOUR AU - Guancial, E. A. AU - Roussel, B. AU - Bergsma, D. P. AU - Bylund, K. C. AU - Sahasrabudhe, D. AU - Messing, E. PY - 2015 DA - 2015// TI - Bladder cancer in the elderly patient: Challenges and solutions JO - Clinical Interventions in Aging VL - 10 ID - Guancial2015 ER - TY - JOUR AU - Scosyrev, E. AU - Wu, G. AU - Golijanin, D. AU - Messing, E. PY - 2013 DA - 2013// TI - Non-bladder cancer mortality in patients with urothelial cancer of the bladder JO - Urologic Oncology VL - 31 UR - https://doi.org/10.1016/j.urolonc.2011.03.005 DO - 10.1016/j.urolonc.2011.03.005 ID - Scosyrev2013 ER - TY - JOUR AU - Meeks, J. J. AU - Bellmunt, J. AU - Bochner, B. H. AU - Clarke, N. W. AU - Daneshmand, S. AU - Galsky, M. D. PY - 2012 DA - 2012// TI - A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer JO - European Urology VL - 62 UR - https://doi.org/10.1016/j.eururo.2012.05.048 DO - 10.1016/j.eururo.2012.05.048 ID - Meeks2012 ER - TY - JOUR AU - Niegisch, G. AU - Lorch, A. AU - Droller, M. J. AU - Lavery, H. J. AU - Stensland, K. D. AU - Albers, P. PY - 2013 DA - 2013// TI - Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: Which patients benefit? JO - European Urology VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.06.002 DO - 10.1016/j.eururo.2013.06.002 ID - Niegisch2013 ER - TY - JOUR AU - Kaufman, D. S. AU - Shipley, W. U. AU - Feldman, A. S. PY - 2009 DA - 2009// TI - Bladder cancer JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60491-8 DO - 10.1016/S0140-6736(09)60491-8 ID - Kaufman2009 ER - TY - STD TI - Taarnhoej GA, Lindberg H, Johansen C, Pappot H. Patient-reported outcomes and quality of life in bladder cancer patients receiving chemotherapy; a real-life experience. Under review in Scientific Reports. 2019. ID - ref17 ER - TY - JOUR AU - Rosenberg, J. E. AU - Hoffman-Censits, J. AU - Powles, T. AU - Heijden, M. S. AU - Balar, A. V. AU - Necchi, A. PY - 2016 DA - 2016// TI - Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial JO - Lancet. VL - 387 UR - https://doi.org/10.1016/S0140-6736(16)00561-4 DO - 10.1016/S0140-6736(16)00561-4 ID - Rosenberg2016 ER - TY - JOUR AU - Bellmunt, J. AU - Wit, R. AU - Vaughn, D. J. AU - Fradet, Y. AU - Lee, J. L. AU - Fong, L. PY - 2017 DA - 2017// TI - Pembrolizumab as second-line therapy for advanced urothelial carcinoma JO - The New England Journal of Medicine VL - 376 UR - https://doi.org/10.1056/NEJMoa1613683 DO - 10.1056/NEJMoa1613683 ID - Bellmunt2017 ER - TY - JOUR AU - Trask, P. C. AU - Dueck, A. C. AU - Piault, E. AU - Campbell, A. PY - 2018 DA - 2018// TI - Patient-reported outcomes version of the common terminology criteria for adverse events: Methods for item selection in industry-sponsored oncology clinical trials JO - Clinical Trials (London, England) VL - 15 UR - https://doi.org/10.1177/1740774518799985 DO - 10.1177/1740774518799985 ID - Trask2018 ER - TY - JOUR AU - Schmidt, H. AU - Merkel, D. AU - Koehler, M. AU - Flechtner, H. H. AU - Sigle, J. AU - Klinge, B. PY - 2016 DA - 2016// TI - PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study JO - Support Care Cancer VL - 24 UR - https://doi.org/10.1007/s00520-015-3055-4 DO - 10.1007/s00520-015-3055-4 ID - Schmidt2016 ER - TY - JOUR AU - Nordan, L. AU - Blanchfield, L. AU - Niazi, S. AU - Sattar, J. AU - Coakes, C. E. AU - Uitti, R. PY - 2018 DA - 2018// TI - Implementing electronic patient-reported outcomes measurements: Challenges and success factors JO - BMJ Quality and Safety VL - 27 UR - https://doi.org/10.1136/bmjqs-2018-008426 DO - 10.1136/bmjqs-2018-008426 ID - Nordan2018 ER - TY - JOUR AU - Taarnhoj, G. A. AU - Johansen, C. AU - Pappot, H. PY - 2019 DA - 2019// TI - Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature JO - Health and Quality of Life Outcomes VL - 17 UR - https://doi.org/10.1186/s12955-018-1077-6 DO - 10.1186/s12955-018-1077-6 ID - Taarnhoj2019 ER - TY - JOUR AU - Hasson, F. AU - Keeney, S. AU - McKenna, H. PY - 2000 DA - 2000// TI - Research guidelines for the Delphi survey technique JO - Journal of Advanced Nursing VL - 32 ID - Hasson2000 ER - TY - JOUR AU - Christensen, A. I. AU - Ekholm, O. AU - Gray, L. AU - Glümer, C. AU - Juel, K. PY - 2015 DA - 2015// TI - What is wrong with non-respondents? Alcohol-, drug- and smoking-related mortality and morbidity in a 12-year follow-up study of respondents and non-respondents in the Danish health and morbidity survey JO - Addiction. VL - 110 UR - https://doi.org/10.1111/add.12939 DO - 10.1111/add.12939 ID - Christensen2015 ER - TY - JOUR AU - Tolonen, H. AU - Laatikainen, T. AU - Helakorpi, S. AU - Talala, K. AU - Martelin, T. AU - Prattala, R. PY - 2010 DA - 2010// TI - Marital status, educational level and household income explain part of the excess mortality of survey non-respondents JO - European Journal of Epidemiology VL - 25 UR - https://doi.org/10.1007/s10654-009-9389-9 DO - 10.1007/s10654-009-9389-9 ID - Tolonen2010 ER - TY - JOUR AU - Une, H. AU - Miyazaki, M. AU - Momose, Y. PY - 2000 DA - 2000// TI - Comparison of mortality between respondents and non-respondents in a mail survey JO - Journal of Epidemiology VL - 10 UR - https://doi.org/10.2188/jea.10.136 DO - 10.2188/jea.10.136 ID - Une2000 ER -